Path 10 from C00279,C00074 to C00082

Back to all pathways

Sources: D-Erythrose 4-phosphate (C00279) Phosphoenolpyruvate; (C00074)

Target:L-Tyrosine; (C00082)

Z: 1.0
Composite map: C00279->C00082:[10->10,6->9,7->11,8->12], C00074->C00082:[6->1,6->7,7->2,8->3,8->8]

Showing 1 best reactions for each rpair.

RPAIRReactionScoreSeq1Seq2EvalueECsEquation
RP01568R01518452TRIRE0077656Q747Q8|GPMI_GEOSL e-1275.4.2.1 2-Phospho-D-glycerate; <=> 3-Phospho-D-glycerate;
RP01785R01826706TRIRE0078347P80576|AROF_NEUCR 0.02.5.1.54 H2O; + D-Erythrose 4-phosphate + Phosphoenolpyruvate; <=> Orthophosphate; + 2-Dehydro-3-deoxy-D-arabino-heptonate 7-phosphate;
RP02170R02382588TRIRE0056646P46882|AOFN_ASPNG e-1681.4.3.4 Tyramine; + Oxygen; + H2O; <=> 4-Hydroxyphenylacetaldehyde; + NH3; + H2O2;
RP00036R018581069TRIRE0078439P31865|KPYK_TRIRE 0.02.7.1.40 dGTP; + Pyruvate; <=> Phosphoenolpyruvate; + dGDP;
RP00123R02078266TRIRE0050793P00440|TYRO_NEUCR 7e-711.14.18.1 Oxygen; + 3,4-Dihydroxy-L-phenylalanine; + L-Tyrosine; <=> 3,4-Dihydroxy-L-phenylalanine; + H2O; + Dopaquinone
RP00113R01512801TRIRE0021406P14228|PGK_TRIRE 0.02.7.2.3 3-Phospho-D-glycerate; + ATP; <=> 3-Phospho-D-glyceroyl phosphate; + ADP;
RP02171R02383413TRIRE0069696P54989|NTAA_CHEHE e-1151.14.13.- Tyramine; + Oxygen; + NADH; + H <=> NAD+; + H2O; + Dopamine;
RP01711R01715234TRIRE0120219P32178|CHMU_YEAST 2e-615.4.99.5 Chorismate; <=> Prephenate;
RP01710R01714535TRIRE0023298Q12640|AROC_NEUCR e-1524.2.3.5 5-O-(1-Carboxyvinyl)-3-phosphoshikimate; <=> Chorismate; + Orthophosphate;
RP01033R00658777TRIRE0120568Q76KF9|ENO_PENCH 0.04.2.1.11 2-Phospho-D-glycerate; <=> H2O; + Phosphoenolpyruvate;
RP01784R01826706TRIRE0078347P80576|AROF_NEUCR 0.02.5.1.54 H2O; + D-Erythrose 4-phosphate + Phosphoenolpyruvate; <=> Orthophosphate; + 2-Dehydro-3-deoxy-D-arabino-heptonate 7-phosphate;
RP00334R01730478TRIRE0046545O60078|TYR1_SCHPO e-1341.3.1.13 NADP+; + Prephenate; <=> 3-(4-Hydroxyphenyl)pyruvate; + NADPH; + H+ + CO2;
RP00395R01061612TRIRE0119735P17730|G3P2_TRIKO e-1751.2.1.12 NAD+; + D-Glyceraldehyde 3-phosphate; + Orthophosphate; <=> NADH; + 3-Phospho-D-glyceroyl phosphate; + H
RP13340R01827443TRIRE0123026O42700|TAL1_SCHPO e-1242.2.1.2 Sedoheptulose 7-phosphate; + D-Glyceraldehyde 3-phosphate; <=> D-Erythrose 4-phosphate + beta-D-Fructose 6-phosphate
RP01790R01830931TRIRE0120635Q12630|TKT1_KLULA 0.02.2.1.1 D-Glyceraldehyde 3-phosphate; + beta-D-Fructose 6-phosphate <=> D-Xylulose 5-phosphate + D-Erythrose 4-phosphate
RP05698R00006793TRIRE0074123P07342|ILVB_YEAST 0.02.2.1.6 CO2; + 2-Acetolactate <=> Pyruvate;
RP02189R024121637TRIRE0082516P07547|ARO1_EMENI 0.04.2.3.4,2.5.1.19,2.7.1.71,4.2.1.10,1.1.1.25 ATP; + Shikimate; <=> Shikimate 3-phosphate; + ADP;
RP00577R024131637TRIRE0082516P07547|ARO1_EMENI 0.04.2.3.4,2.5.1.19,2.7.1.71,4.2.1.10,1.1.1.25 NADP+; + Shikimate; <=> NADPH; + 3-Dehydroshikimate + H
RP06826R02080370TRIRE0078552P20711|DDC_HUMAN e-1024.1.1.28 3,4-Dihydroxy-L-phenylalanine; <=> CO2; + Dopamine;
RP03070R034601637TRIRE0082516P07547|ARO1_EMENI 0.04.2.3.4,2.5.1.19,2.7.1.71,4.2.1.10,1.1.1.25 Phosphoenolpyruvate; + Shikimate 3-phosphate; <=> 5-O-(1-Carboxyvinyl)-3-phosphoshikimate; + Orthophosphate;
RP02750R030841637TRIRE0082516P07547|ARO1_EMENI 0.04.2.3.4,2.5.1.19,2.7.1.71,4.2.1.10,1.1.1.25 3-Dehydroquinate; <=> 3-Dehydroshikimate + H2O;
RP01958R02080370TRIRE0078552P20711|DDC_HUMAN e-1024.1.1.28 3,4-Dihydroxy-L-phenylalanine; <=> CO2; + Dopamine;
RP03071R034601637TRIRE0082516P07547|ARO1_EMENI 0.04.2.3.4,2.5.1.19,2.7.1.71,4.2.1.10,1.1.1.25 Phosphoenolpyruvate; + Shikimate 3-phosphate; <=> 5-O-(1-Carboxyvinyl)-3-phosphoshikimate; + Orthophosphate;
RP02749R030831637TRIRE0082516P07547|ARO1_EMENI 0.04.2.3.4,2.5.1.19,2.7.1.71,4.2.1.10,1.1.1.25 2-Dehydro-3-deoxy-D-arabino-heptonate 7-phosphate; <=> Orthophosphate; + 3-Dehydroquinate;
RP02956R03341533TRIRE0121534P16467|PDC5_YEAST e-1514.1.1.1,4.1.1.- 3-(4-Hydroxyphenyl)pyruvate; <=> CO2; + 4-Hydroxyphenylacetaldehyde;

Pathway diagram (see pathway with molecule structures instead)